Rhoda M. Alani, M.D., Herbert Mescon Professor and Chair, Department of Dermatology, Boston University School of Medicine; Dermatologist-in-Chief, Boston Medical Center, will present her seminar "Targeting p300 HAT Activity as a Novel Anticancer Strategy."